Coronavirus | Remdesivir production expected to start in Maharashtra’s Wardha from 28th April: Nitin Gadkari
The Hindu
Genetek LifeSciences to produce 30,000 vials of remdesivir injections per day, says the Union Minister
Union minister Nitin Gadkari on Tuesday said Genetek LifeSciences will start production of remdesivir injections, used in the treatment of COVID-19, in Wardha (Maharashtra) from Wednesday. While speaking to reporters during the inauguration of a COVID-care centre in Nagpur, Mr. Gadkari said the company will produce 30,000 vials per day. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.More Related News













